all - Opinion Summaries
Page 14 of 88
Showing Result 131 - 140 of 874
| Description | Date | Docket # |
|---|---|---|
Senju Pharmaceutical Co. v. Lupin LimitedUnited States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentIn this patent infringement action, plaintiffs sued defendants for infringement of claims 6 and 12-16 of their reexamined '045 patent, which relates... |
03/20/2015 | 13-1630 |
US v. Brigham and Women's HospitalUnited States First Circuit
Civil Procedure, Drugs & Biotech, Government Benefits, Health LawIn this case, relator Jones alleges that defendants Killiany and Albert knowingly made false statements when submitting a grant application to the... |
03/16/2015 | 13-1973 |
Zak v. Chelsea Therapeutics InternationalUnited States Fourth Circuit
Civil Procedure, Class Actions, Drugs & Biotech, Securities LawIn this securities class action, plaintiff-shareholders brought suit against defendant Chelsea Therapeutics International and its corporate officers,... |
03/16/2015 | 13-2370 |
In re Nexium Antitrust LitigationUnited States First Circuit
Drugs & Biotech, Antitrust & Trade Regulation, Consumer Protection LawIn this class action involving sale of a prescription heartburn drug, plaintiffs assert that, but for defendants anti-competitive conduct, a generic... |
01/22/2015 | 14-1521 |
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.United States Supreme Court
Civil Procedure, Drugs & Biotech, Intellectual Property, PatentIn this patent infringement case involving a multiple sclerosis drug, the district court concluded that the patent claim was sufficiently definite and... |
01/20/2015 | 13-854 |
University of Utah Research v. Ambry GeneticsUnited States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentIn this patent litigation, plaintiff Myriad, owner of the '441, '282, and '492 patents which cover compositions of matter and methods relating to the... |
12/17/2014 | 14-1361 |
Promega Corp v. Life TechUnited States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentIn this patent litigation, summary judgment against defendant LifeTech finding that the asserted claims of plaintiff Promega's '660, '235, and '771... |
12/15/2014 | 13-1011 |
Sandoz v. AmgenUnited States Federal Circuit
Civil Procedure, Drugs & Biotech, Health Law, Intellectual Property, PatentIn this patent infringement case, plaintiff sought a declaratory judgment that two patents licensed exclusively to defendant are invalid and... |
12/05/2014 | 14-1693 |
PAR Pharmaceutical v. TWI PharmaceuticalsUnited States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentIn this patent litigation involving U.S. Patent No. 7,101,576 (Patent 576), which claims methods of using nanosized formulations of the drug megestrol... |
12/03/2014 | 14-1391 |
Roche Vitamins, Inc. v. USUnited States Federal Circuit
Drugs & Biotech, International TradeDecision of the United States Court of International Trade reclassifying plaintiff's "BetaTab" product as "Provitamins, unmixed" under subheading... |
11/20/2014 | 13-1568 |
Results 131 to 140 of 874